Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Asenapine in Acute Schizophrenia
NCT01617187Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Dec 2012
- Primary completion
- Aug 2014
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of asenapine in schizophrenia, sponsored by Organon & Co.. Started Dec 2012; status: completed.
02
Drugs
asenapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01617187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01617187.